To identify LincIN-interacting protein partner(s) that may contribute to its function in breast cancer development, we used in vitro transcribed biotin-labeled full-length LincIN for pull-down experiments followed with protein identification by mass spectrometry (MS) (Fig. 4a). This evidence concerns the gene ITGB1-DT and breast cancer.